Weight loss, quality of life and employment status after Roux-en-Y gastric bypass: 5-year analysis.

Background: Obesity can have a tremendous impact on the psychosocial, physical, and economic health of those afflicted by it. We hypothesized that if surgery results in significant weight loss and improves quality of life, those unemployed and disabled as a result of their morbid obesity might be more likely to become gainfully employed after Roux-en-Y gastric bypass (RYGBP).

Methods: We reviewed the medical charts of all patients who underwent RYGBP from April 1998 to December 1999.

Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass.

Purpose: Many women with polycystic ovarian syndrome (PCOS) are overweight. This study investigated the impact of weight loss surgery on the clinical manifestations of this disorder in morbidly obese women with PCOS-a major risk factor for the development of heart disease, stroke, and type II diabetes.

Methods: We reviewed the outcomes of women diagnosed with PCOS who had undergone weight loss surgery at the University of Pittsburgh between July 1997 and November 2001.

Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome.

Objective: To evaluate the effects of surgical weight loss on fatty liver disease in severely obese patients.

Summary Background Data: Nonalcoholic fatty liver disease (NAFLD), a spectrum that extends to liver fibrosis and cirrhosis, is rising at an alarming rate. This increase is occurring in conjunction with the rise of severe obesity and is probably mediated in part by metabolic syndrome (MS).